Jörg Hausleiter
Latest contributions
Transcatheter tricuspid valve replacement - The fundamentals
26 Nov 2024 – From PCR London Valves 2024
Interested in learning the key steps for successful transcatheter tricuspid valve replacement?
Join this session to refine your skills in patient selection, procedural planning and execution. You'll explore a real-world case of a 62-year-old patient with heart failure symptoms and gain insights from the TRISCEND II study.
Multivalve disease: defining pathways for optimal assessment and treatment in the absence of good clinical evidence
26 Nov 2024 – From PCR London Valves 2024
Curious about managing multivalve disease in the absence of robust clinical evidence? This video is a must-watch!
You'll explore the latest strategies for assessing and treating this condition (including advanced multimodality investigations like echocardiography, magnetic resonance and cardiac catheterisation), and learn how to evaluate cardiopulmonary interactions and...
Transcatheter mitral valve replacement - Are we there yet?
25 Nov 2024 – From PCR London Valves 2024
Are we ready to embrace transcatheter mitral valve replacement (TMVR) as the next big step in mitral interventions? Find out in this must-watch video!
Discover the key anatomical factors that favor TMVR over TEER, get acquainted with cutting-edge TMVR platforms like Tioga, Cephea and Intrepid, and master...
Breaking barriers in tricuspid valve repair
25 Nov 2024 – From PCR London Valves 2024
What’s driving the future of transcatheter tricuspid valve repair (TTVR)? Dive into the latest breakthroughs with this video!
Gain insights into real-world outcomes from TTVR registries, uncover key findings from the TriCLASP study, explore how TriClip TEER reshapes the right heart, learn how pulmonary hypertension influences TTVR...
Tailoring tricuspid interventions with the EVOQUE and PASCAL Precision systems
25 Nov 2024 – From PCR London Valves 2024
Catch up on this engaging session, featuring a parallel case study of two high-risk patients with severe tricuspid regurgitation. Discover how the PASCAL system is used to treat diverse TR anatomies and explore patient selection and management strategies for the EVOQUE system. Watch a recorded case...
Featured cases - Challenging tricuspid interventions (Part 1)
24 Nov 2024 – From PCR London Valves 2024
Immerse yourself in a captivating collection of featured cases showcasing the latest advances in transcatheter tricuspid valve interventions. Witness groundbreaking techniques, including the first TTVR designed to reduce afterload mismatch, the management of atrial embolization, and the use of intracardiac echocardiography. Explore complex anatomies, failed prior...
Advanced mitral TEER - LIVE case
Recommended by PCR
24 Nov 2024 – From PCR London Valves 2024
Join us for a LIVE case followed by a recorded case highlighting advanced treatments for severe secondary mitral regurgitation:
- A 75-year-old man with permanent AF, a history of CABG, and symptomatic severe secondary MR (atrial and ischemic causes) with low LV function (45%) underwent mitral repair with...
Patient management before, during, and after transcatheter tricuspid valve replacement
16 May 2024 – From EuroPCR 2024
In this session, explore key aspects of transcatheter tricuspid valve replacement, including the role of right ventricular function, pre-procedural hemodynamics, and factors that contribute to procedural success or failure, and gain insights into patient selection criteria, essential imaging techniques, and best practices for post-procedural care, both...
PASCAL Precision system simulation showcase: grasp the difference!
16 May 2024 – From EuroPCR 2024
In this EuroPCR 2024 session, explore a transcatheter edge-to-edge mitral valve repair case, delve into discussions backed by simulation, evidence, and real-world cases to understand atraumatic clasp and closure techniques and predictable implant release. Additionally, gain insights into real-world evidence for tricuspid TEER from the EuroTR trial...
Mitral and tricuspid hotline
16 May 2024 – From EuroPCR 2024
This session provides updates on the latest developments in transcatheter mitral and tricuspid valve interventions. Key topics include one-year outcomes of the MiCLASP study on transcatheter mitral repair, the impact of residual mitral and tricuspid regurgitation after transcatheter repair, and the early feasibility of the AltaValve...
Elevating quality of heart valve treatment through innovation: SAPIEN 3 Ultra RESILIA and EVOQUE valve systems
14 May 2024 – From EuroPCR 2024
Watch this session to explore how the SAPIEN 3 Ultra RESILIA valve can enhance lifetime management for patients, to find out more about the new treatment options available with the EVOQUE valve, identifying the patient populations that stand to benefit the most, and, additionally, to get...
How to identify patients for tricuspid interventions
14 Dec 2023
Watch the replay of this webinar with J. Hausleiter, P. Lüdike, M. Adamo, N. Karam and N. Wunderlich to know more about the clinical presentation and medical therapy of patients with tricuspid regurgitation and much more!
Patient selection for tricuspid intervention - the role of the right heart
30 Nov 2023 – From PCR London Valves 2023
Interviewed by Jörg Hausleiter, Rebecca Hahn and Philipp Lurz provide insight into the right heart's role in tricuspid procedures.
How can we best assess right heart function in patients so as to choose the most appropriate therapy for them? How TTE and TEE can help? How can...
Transcatheter tricuspid valve intervention - Too many patients, too little evidence
21 Nov 2023 – From PCR London Valves 2023
Watch this tricuspid valve session to explore the evolution of transcatheter tricuspid intervention, from a once deemed crazy concept to an everyday procedure. Reflect on the choice between replacement and repair for the tricuspid valve and understand the necessity of a multidisciplinary approach, uniting specialists in...
Innovations in transcatheter tricuspid valve intervention - LIVE case
21 Nov 2023 – From PCR London Valves 2023
Consult this session to discover the new transcatheter treatment strategies, improve your understanding of the clinical indications for intervention, and appreciate the challenges and limitations of tricuspid valve imaging before and during the intervention.
- LIVE case: An 81-year-old woman with permanent AF presents a symptomatic torrential TR with right...
Recent clinical evidence for mitral TEER the CLASP IID trial
06 Dec 2023 – From PCR London Valves 2023
What is the CLASP IID registry and what are the key learnings from 1-year data? Philipp Lurz and Jörg Hausleiter describe the methodology of the programme which compares Pascal vs Mitraclip in patients with degenerative mitral regurgitation. Discover the key findings which are relevant to your practice.
This...
Advancing valve repair: mastering diverse mitral and tricuspid regurgitation anatomies with the PASCAL Precision system
20 Nov 2023 – From PCR London Valves 2023
Participate in this session to stay informed about the latest clinical and real-world evidence for mitral and tricuspid TEER using PASCAL. Explore case-based discussions on mitral regurgitation treatment using PASCAL Precision, and actively participate in an educational tricuspid TEER recorded case procedure featuring the PASCAL Precision.
Tricuspid valve intervention in complex scenarios - Lead-related tricuspid regurgitation
20 Nov 2023 – From PCR London Valves 2023
Join this session to delve into the incidence, outcomes, and survival of patients experiencing tricuspid regurgitation following lead placement. Explore contemporary outcomes of transcatheter edge-to-edge repair for lead-related tricuspid regurgitation, and gain insights into imaging assessment approaches for this condition.
The catheter-based treatment revolution is just getting started
19 Nov 2023 – From PCR London Valves 2023
Consult this session to stay updated on the latest advancements in transcatheter aortic valve implantations and interventions for tricuspid regurgitation. Gain insights into how recent evidence and innovations are reshaping the treatment landscape for valvular heart disease.
Valvular heart disease: novel transcatheter approaches
18 May 2023 – From EuroPCR 2023
Explore this thrilling session on transcatheter approaches for valvular heart disease, featuring the latest advancements, emerging techniques, and revolutionary research. Join your peer as they present novel strategies and devices aimed at improving valvular disease management.
Tailoring tricuspid regurgitation patient treatment with the PASCAL Precision system
17 May 2023 – From EuroPCR 2023
Watch this session to discuss exciting cases of tricuspid regurgitation, learn about the proposed new integrated classification for tricuspid regurgitation and enjoy a live presentation of the PASCAL Precision Repair System using a beating heart simulator, among others!
Increase the complexity: multivalvular coronary interventions
17 May 2023 – From EuroPCR 2023
Investigate the increasing complexity of multivalvular coronary interventions in this insightful case-based presentation. Witness the complex challenges faced and discover the innovative approaches used to navigate the complex procedures.
Transcatheter tricuspid valve interventions: procedural considerations
11 Mar 2023 – From PCR Imaging Valves Madrid 2023
Consult this session on transcatheter tricuspid valve interventions to know more about what to do before planning tricuspid regurgitation interventions, to understand when to perform a right heart catheterisation and to learn how to solve complications during interventions.
Diagnosis and classification of tricuspid regurgitation
11 Mar 2023 – From PCR Imaging Valves Madrid 2023
Watch this session to learn more about the anatomy of the tricuspid valve and its challenges, to know when and how to treat tricuspid regurgitation, and to discover all about the latest classification regarding this condition.
Mitral repair with the PASCAL Precision system
Join this discussion recorded in the PCR Live studio in London, where Sam Dawkins and Wolfgang Rottbauer, hosted by Jörg Hausleiter, talk about some new studies and clinical trials presented during PCR London Valves 2022. They also discuss the latest technologies available to treat mitral regurgitation.
View...
Transcatheter mitral valve interventions: clinical outcomes 1
28 Nov 2022 – From PCR London Valves 2022
Consult this session on transcatheter mitral valve interventions to discover a selection of abstracts submitted during PCR London Valves 2022: one-year outcomes for transcatheter mitral repair from the MiCLASP study, the Edwards PASCAL transcatheter mitral valve repair system study, one-year outcomes of Tendyne TMVR treating symptomatic MR,...
Mitral - Late-Breaking Trials and Innovations
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of late-breaking trials presented during PCR LV 2022: TENDyne European expeRience registry, CLASP IID trial, EXPAND G4, and much more!
Innovations in transcatheter tricuspid valve intervention - LIVE case
28 Nov 2022 – From PCR London Valves 2022
Watch two very innovative tricuspid cases you've never seen before:
- Part 1: TR replacement
An 82-year-old male with chronic atrial fibrillation and completely PM dependent for 27 years, presents a symptomatic torrential TR and an enlarged annulus with a great gap. The operators implanted for the first time in...
Reinventing the treatment of patients with tricuspid valve disease
28 Nov 2022 – From PCR London Valves 2022
This innovative session takes you through the patient selection and anatomical characteristics when selecting amongst the different transcatheter options to treat tricuspid regurgitation, followed by a recorded demonstration using the PASCAL Precision repair system.
Secondary mitral regurgitation: challenges in management
28 Nov 2022 – From PCR London Valves 2022
Consult this session dedicated to secondary mitral regurgitation to learn more about the patients who benefit most from valve intervention, the transcatheter edge-to-edge repair strategies in secondary MR and how to optimally select patients with secondary MR for valve replacement.
